|
DTWD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.067600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.075180E-01 |
| Normal-vs-Stage2 |
2.663200E-01 |
| Normal-vs-Stage3 |
2.418400E-01 |
| Normal-vs-Stage4 |
1.022040E-01 |
| Stage1-vs-Stage2 |
8.982800E-01 |
| Stage1-vs-Stage3 |
1.559870E-04 |
| Stage1-vs-Stage4 |
9.56509999999744E-05 |
| Stage2-vs-Stage3 |
5.954100E-02 |
| Stage2-vs-Stage4 |
2.734200E-02 |
| Stage3-vs-Stage4 |
4.451200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.546800E-01 |
| Normal-vs-AfricanAmerican |
7.309600E-01 |
| Normal-vs-Asian |
5.039400E-01 |
| Caucasian-vs-AfricanAmerican |
9.816200E-01 |
| Caucasian-vs-Asian |
6.450600E-01 |
| AfricanAmerican-vs-Asian |
6.117400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.349200E-01 |
| Normal-vs-Female |
2.310000E-01 |
| Male-vs-Female |
9.237700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.285400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.140000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.154000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.720200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.275600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.827400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.932600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.700800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.064400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.460200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.340800E-03 |
| Normal-vs-Grade 2 |
1.015530E-02 |
| Normal-vs-Grade 3 |
2.767600E-01 |
| Normal-vs-Grade 4 |
9.016600E-03 |
| Grade 1-vs-Grade 2 |
8.002400E-02 |
| Grade 1-vs-Grade 3 |
1.006580E-04 |
| Grade 1-vs-Grade 4 |
1.778649999995E-05 |
| Grade 2-vs-Grade 3 |
6.89669999998088E-07 |
| Grade 2-vs-Grade 4 |
1.28779999997164E-08 |
| Grade 3-vs-Grade 4 |
1.431800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.338000E-03 |
| Normal-vs-ccB subtype |
9.211600E-02 |
| ccA subtype-vs-ccB subtype |
5.19030041168378E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.867200E-01 |
| Normal-vs-N1 |
5.561900E-02 |
| N0-vs-N1 |
5.304100E-02 |
|
|
